Targeting c-Met in breast cancer: From mechanisms of chemoresistance to novel therapeutic strategies
{{output}}
Breast cancer presents a significant challenge due to its heterogeneity and propensity for developing chemoresistance, particularly in the triple-negative subtype. c-Mesenchymal epithelial transition factor (c-Met), a receptor tyrosine kinase, presents a promi... ...
